Tack J, Vanden Berghe P, Coulie B, Janssens J
Center for G.I. Research K.U. Leuven, Belgium, University of Leuven, Leuven, Belgium.
Neurogastroenterol Motil. 2007 Jan;19(1):39-46. doi: 10.1111/j.1365-2982.2006.00839.x.
Sumatriptan, a 5-hydroxytryptamine(1D) (5-HT(1D))-receptor agonist used in the treatment in migraine, inhibits gastric motility via the enteric nervous system. As no studies have reported enteric neuronal 5-HT(1D) receptors, we used conventional intracellular recordings to characterize the actions of sumatriptan on 145 guinea-pig antral myenteric neurones. In 24 of 29 neurones with a 5-HT(1P) receptor-mediated depolarizing response to 5-HT, application of sumatriptan caused a dose-dependent depolarization, accompanied by increased membrane resistance and enhanced excitability. Depolarizing responses to sumatriptan occurred both in cholinergic and in nitrergic neurones. Sumatriptan did not mimic the 5-HT(3) receptor-mediated fast-depolarizing responses or 5-HT(1A) receptor-mediated inhibitory responses to 5-HT. Sumatriptan had no effect on neurones not responding to 5-HT. The depolarizing response to sumatriptan was inhibited by renzapride, but not by 5-HT(1-7) receptor antagonists. We conclude that sumatriptan behaves as an agonist at the 5-HT(1P) receptor on myenteric neurones in the guinea-pig gastric antrum. The actions of sumatriptan on gastric motility seem to be attributable to a direct action on enteric neurones.
舒马曲坦是一种用于治疗偏头痛的5-羟色胺(1D)(5-HT(1D))受体激动剂,它通过肠神经系统抑制胃动力。由于尚无研究报道肠神经元5-HT(1D)受体,我们采用传统的细胞内记录法来描述舒马曲坦对145只豚鼠胃窦肌间神经丛神经元的作用。在对5-HT有5-HT(1P)受体介导的去极化反应的29个神经元中的24个中,应用舒马曲坦引起剂量依赖性去极化,伴有膜电阻增加和兴奋性增强。对舒马曲坦的去极化反应在胆碱能神经元和氮能神经元中均有发生。舒马曲坦不会模拟5-HT(3)受体介导的快速去极化反应或5-HT(1A)受体介导的对5-HT的抑制反应。舒马曲坦对不响应5-HT的神经元没有影响。对舒马曲坦的去极化反应被雷尼替丁抑制,但不被5-HT(1-7)受体拮抗剂抑制。我们得出结论,舒马曲坦在豚鼠胃窦肌间神经丛神经元的5-HT(1P)受体上表现为激动剂。舒马曲坦对胃动力的作用似乎归因于对肠神经元的直接作用。